Innovative Health’s mission is to enable hospitals, manufacturers, and physicians to provide better care for cardiology patients through significant device cost savings, which lead to reduced procedure costs and the ability to access new technology and improve patient care. 

Single-use device reprocessing has the potential to reduce medical device costs in cardiology procedures by 30% without adding risk, freeing resources for hospitals to invest in better care. Innovative Health is leading the development of new reprocessing technologies that help hospitals reduce cardiology costs significantly.

This project is a major success in the US, offering win/ win work relations with hospitals, reducing their operating cost, offering more patients traffic, & satisfying more customers. It is expected to yield a revenue exceeding 75M$. With high expectation, next year, as more and more catheters reprocessing procedures are adopted.

Revanix international will bring this Breakthrough Re-possessing technology which is FDA approved and significantly adopted by major hospitals in the USA to the gulf region. Aiming, to provide immediately affordable Catheters to gulf markets , and long term, to build a medical complex Hub, replicating the US Facilities and serving regional hospitals, while operated and managed by local talents trained and fully equipped,